中国P站

Chronic inflammation; Cancer prevention; Anti-inflammatory diet; Nutritional strategies; Immune modulation; Oxidative stress; Dietary patterns; Whole foods; Plant-based nutrition; Functional foods; Inflammatory biomarkers; Gut microbiome; Lifestyle intervention; Nutrigenomics; Preventive oncology

Introduction

Chronic inflammation is increasingly recognized as a key contributor to the development and progression of various cancers. Unlike acute inflammation, which is a protective immune response to injury or infection, chronic inflammation persists over time and may result in cellular damage, DNA mutations, and altered immune function. This low-grade, systemic inflammation is often linked to lifestyle factors, including poor dietary habits. As a result, there is growing interest in dietary interventions that can modulate inflammatory pathways and reduce cancer risk [1-5]. Nutritional strategies aimed at targeting inflammation focus on increasing the intake of foods rich in antioxidants, phytochemicals, and omega-3 fatty acids while reducing pro-inflammatory components such as processed meats, sugars, and trans fats. These approaches not only support immune health but also address the underlying metabolic and cellular processes involved in carcinogenesis. In the context of cancer prevention, diet represents a modifiable and non-invasive tool with significant potential for population-level impact. The integration of anti-inflammatory nutrition into public health policies and clinical practice is an important step toward reducing the global cancer burden [6-10].

Discussion

Chronic inflammation contributes to cancer through several biological mechanisms, including the production of reactive oxygen species (ROS), activation of nuclear factor-kappa B (NF-κB), and promotion of angiogenesis and cellular proliferation. Persistent inflammatory signaling can suppress normal apoptosis and enhance the survival of damaged cells, ultimately creating an environment conducive to tumor formation. Dietary patterns that emphasize whole, plant-based foods have been shown to counteract these effects. For instance, polyphenols in berries and green tea, curcumin in turmeric, and flavonoids in leafy greens possess strong anti-inflammatory and antioxidant properties. These compounds help reduce oxidative stress, inhibit pro-inflammatory cytokines, and regulate gene expression involved in immune function.

Omega-3 fatty acids found in fatty fish, walnuts, and flaxseeds play a key role in resolving inflammation by shifting the balance toward anti-inflammatory eicosanoids. Similarly, dietary fiber from whole grains, fruits, and legumes promotes gut health and fosters a diverse microbiome, which is essential for immune regulation and inflammation control. A healthy gut microbiota produces short-chain fatty acids (SCFAs) such as butyrate, which have been shown to suppress inflammatory processes and protect against colorectal cancer.

Numerous studies, including observational cohorts and randomized controlled trials, support the association between anti-inflammatory diets and reduced cancer risk. The Mediterranean diet, for example, has been linked to lower incidence rates of breast, prostate, and colorectal cancers. This diet includes high consumption of fruits, vegetables, olive oil, legumes, and moderate intake of fish and dairy, providing a balanced intake of micronutrients and bioactive compounds that combat inflammation.

Emerging fields like nutrigenomics further enhance our understanding of how dietary components interact with genetic pathways related to inflammation and cancer. Personalized nutrition plans based on genetic predispositions and biomarker profiles can potentially optimize cancer prevention strategies. Moreover, functional foods such as fermented products, probiotic yogurts, and fortified cereals offer additional avenues for reducing inflammation through targeted nutrient delivery.

Despite the clear benefits, several barriers hinder the widespread adoption of anti-inflammatory diets. These include lack of awareness, cultural dietary preferences, food insecurity, and limited access to fresh produce. Public health efforts must prioritize education, food policy reform, and community-based interventions to make anti-inflammatory nutrition more accessible and sustainable. Integrating nutrition counseling into routine primary care and oncology settings can further promote preventive dietary behaviors.

In addition, lifestyle factors such as physical activity, sleep quality, stress management, and smoking cessation also influence inflammatory status and should be addressed alongside dietary interventions. A holistic approach that combines nutrition with other lifestyle modifications offers the most effective strategy for targeting chronic inflammation and reducing cancer risk.

Conclusion

Targeting chronic inflammation through diet represents a promising and evidence-based approach to cancer prevention. By focusing on anti-inflammatory foods and dietary patterns, individuals can reduce systemic inflammation, strengthen immune function, and interrupt pathways involved in carcinogenesis. Whole foods rich in antioxidants, healthy fats, fiber, and phytonutrients play a central role in this strategy, supported by emerging research in nutrigenomics and gut health. As healthcare systems shift toward prevention-oriented models, the role of diet in managing inflammation must be emphasized through policy, education, and clinical practice. Collaboration among healthcare providers, nutritionists, and policymakers is essential to ensure that anti-inflammatory nutrition becomes a widely adopted and accessible cancer prevention tool. Ultimately, dietary interventions offer a powerful, low-cost, and scalable method to combat chronic inflammation and lower cancer risk across diverse populations.

References

1. Baralt L, Weitz TA (2012) . Womens Health Issues 22: 509-512.

, , 

1. Bob Roehr (2012) . BMJ 344: e870.

, , 

1. Fontana RS, Sanderson DR, Woolner LB, Taylor WF, Miller WE, et al. (1986) . J Occup Med US 28:746-750.

, , 

1. McKinney SM, Sieniek M, Godbole V, Godwin J, Antropova N, et al. (2020). . Nature 577: 89-94.

, , 

1. Secretan BL, Loomis D, Straif K (2015) . N Engl J Med 373: 1479.

, , 

1. Hamashima C, Shibuya D, Yamazaki H, Inoue K, Fukao A, et al. (2008) . Jpn J Clin Oncol 38: 259-267.

, , 

1. Sabatino SA, White MC, Thompson TD, Klabunde NC (2015) . MMWR Morb Mortal Wkly Rep 64: 464-8.

, 

1. White A, Thompson TD, White MC, Sabatino SA, Moor JD, et al. (2017) . MMWR Morb Mortal Wkly Rep 66: 201-206.

, , 

1. Horner-Johnson W, Dobbertin K, Andresen EM, Iezzoni LI, et al. (2014) . Womens Health Issues 24: 47-53.

, , 

1. Horner-Johnson W, Dobbertin K, Iezzoni LI (2015) . Womens Health Issues 25: 246-53.

, ,